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Biologic Evidence for the
Existence of Thresholds in
Chemical Carcinogenesis
by Hans L. Falk*
In a search for evidence for the existence of
threshold levels below which chemical carcinogens
do not induce cancer, it is essential to consider all
aspects of the carcinogenic process. We should not
confine our thoughts solely to the generally ac-
cepted stages of carcinogenesis: initiation, promo-
tion, and progression.
Several factors may influence thresholds even
before the proximate carcinogen reaches the target
tissue. Important is the number of molecules that
can react with the target tissue. Apart from the level
ofexposure, this number depends on several condi-
tions. First, not all molecules with carcinogenic
potential are equally well absorbed, and the degree
ofabsorption will affect the number available. Sec-
ond, not all of the molecules which enter the or-
ganism reach the target tissue. For many molecules,
metabolic change may produce noncarcinogenic de-
rivatives, while others will be activated to the
proximate carcinogen. The ultimate number of
molecules in this group is dependent upon the
metabolic capability ofthe organism to perform the
necessary conversions. This may be a function of
the state of enzyme induction or tissue damage.
Once in the active state, a large proportion of the
carcinogenic molecules may be lost to the car-
cinogenic process by interaction with molecules
other than DNA, that is, with any molecules that
can be alkylated, such as a diversity of small
molecules, with macromolecules, such as protein or
RNA. While damage may result from these reac-
tions, no heritable changes are produced.
From the foregoing, it is evident that several pro-
cesses which have no relationship to car-
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cinogenesis, such as absorption by the organism,
metabolic change, or deactivation of the proximate
carcinogen by abundantly available enzymes such
as epoxide hydrase or glutathione S-transferase and
reaction with molecules other than DNA, have
great bearing on thresholds because of their poten-
tial capacity to reduce the number of active
molecules available for the carcinogenic process.
Additional variables that influence thresholds are
inherent in the reaction between DNA and the
chemicals that are effective alkylating agents.
Those variables that affect DNA repair are espe-
cially critical. First, the extent to which DNA dam-
age can be repaired depends, to some extent, on the
site of alkylation. Some sites are more difficult to
repair than others. For example, it has been found
that tumor production in some tissues is correlated
with persistence ofalkylation at specific locations in
the base, particularly at the 06 guanine position.
Alkylation of the N guanine position was not as-
sociated with cancer production, because elimina-
tion ofthe N7 alkylated guanine is far more efficient
and enzymes more readily available than for the
elimination of an 06-alkyl guanine base (1).
Second, DNA repair of succeeding alkylations is
less effective. Thus, in a situation of continuous
exposure, DNA repair efficiency may be reduced
by subsequent entry ofcarcinogens into the system.
A third condition, which may influence thresholds
is the type of DNA-carcinogen interaction that oc-
curs. For example, crosslinking chemicals produce
DNA damage which is least amenable to repair,
whereas interactions in which only a single arm of
an alkylating agent is bound to DNA bases are
more easily repaired. Finally, as illustrated by the
"SOS repair" in bacteria, DNA repair, when in-
correct, may actually lower the threshold (2). If re-
pair processes are not available, cells whose DNA
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ever, when repair can be initiated, there is the po-
tential for a variety of errors which may result in
inappropriate reconstitution ofDNA. The end result
is a mutation, a case where the cure is worse than
the disease. A related group of variables are those
associated with the site of DNA damage as it re-
lates to DNA function.
As an analogy, ifthere is a typographical error in
this presentation, most of those who read it proba-
bly do not register it, since, like a point mutation, it
does not significantly affect the message ofwhich it
was a part; and like a typographical mistake, most
point mutations need not significantly affect the ex-
pressions of the DNA code (3).
The variables associated with DNA repair and
with the site ofalkylation then are another major set
of factors which potentially influence thresholds.
Successful DNA repair ofa carcinogen-induced le-
sion raises the threshold for cancer; unsuccessful
repair lowers the threshold.
As one of the illustrations in Dr. Rall's paper
indicates, there may be an enormous range for
thresholds: between 104 and 1020 molecules of a
carcinogen. As an actual example, however, 25 ,g
of benzpyrene injected once subcutaneously into
mice may produce some sarcomas (4). At this dose,
the mouse will absorb in the order of 1016 molecules
of benzpyrene. Sarcomas are induced at this dose
level; therefore, the threshold forbenzpyrene under
the conditions specified, is below 1016 molecules.
In a second example, painting a different poly-
cyclic hydrocarbon once on the skin of mice at a
dose of 0.2 ,ug, which is of the order of 1014
molecules, will not produce any tumors. However,
if the carcinogen treated mouse skin is painted
periodically with a promoter, like croton resin or a
phorbol ester, tumors will appear (5). In the first
example then, a definite threshold exists below 1016
molecules ofcarcinogen; in the second example the
threshold is above 1014 molecules unless a promoter
is applied.
The latter example introduces the role played by
promoters in modifying thresholds for carcinogen
action. Experiments on the mechanism of promo-
tion in carcinogenesis consists of exposing the skin
ofgroups ofmice to a dose ofcarcinogen incapable
ofproducing tumors in the experimental group. It is
preferable in this type of study to identify a dose
that will produce no tumors whatsoever in the ex-
perimental population used. The promotion is then
applied to the carcinogen-treated skin. Provided the
promoter is applied for an adequate period, tumors
will usually result.
Roe and others have made major contribution
towards an understanding of the mechanism of
cancer promotion. In these studies, initiation of
cancer in mouse skin has been successfully accom-
plished with many types of carcinogens. This work
has shown that long periods oftreatment of up to a
year or more, are required for tumor promotion (6).
In one study, a year was allowed to elapse between
tumor initiation and the beginning oftreatment with
a promoter, but tumors were still produced, al-
though at a reduced incidence. The explanation for
this phenomenon is that the carcinogenic process in
the initiated cell remains dormant until a stimulus of
as yet unknown nature is supplied by the promoter.
The point here is that, at least in mice, there are
levels of carcinogen exposure which will produce
only dormant, initiated cells unless adequate pro-
motion is supplied. This can be interpreted to mean
that the promoter in effect lowers the threshold for
production of observable tumors.
The promotion phenomenon is even a political
issue, since in one country promotion of car-
cinogenesis has been declared to be only a labora-
tory curiosity and without significance for human
health. This official position is based on the high
doses of promoter required. I agree that practically
all promotion experiments done on mice used large
amounts of croton oil and that humans do not have
their skins painted repeatedly with croton oil. On
this basis, promoter studies are indeed laboratory
curiosities. On the other hand, we all know people
who do chronic experiments on themselves with
cigarette smoke inhalation. This is a similar situa-
tion.
A related situation and one ofmany that has been
documented involves the occupational exposure of
the skin of workers to coal tar and oil fractions,
which frequently yield unexpectedly high cancer in-
cidences (7).
Little information is available on interactions
between structurally related chemicals, particularly
between those which are eithercarcinogens ofdiffe-
rent potency or inactive. There is only fragmentary
knowledge of the types of related compounds to
which the human population may be exposed con-
comitantly with exposure to known carcinogens.
For instance, the identity of all of the components
ofcoal tar which may enter the body after washing
the skin with coal tar soap is unknown as are the
components of the soot that is inhaled by most of
the human inhabitants of the world.
The results of an interaction between such
chemicals in experimental animals depend on the
dose and the type of treatment. Every possible re-
sponse has been reported. In the case ofinteraction
between two "strong" carcinogens or between two
"weak" carcinogens, there are, as anticipated, ad-
ditive effects. On the other hand, combining a
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inhibition of carcinogenesis; the effect of the
"strong" carcinogen is blocked while only that of
the "weak" carcinogen, introduced at higher dose
levels, is expressed (8).
Inhibition of carcinogenesis has an obvious
bearing on cancer thresholds (9). Initial studies on
inhibition date to the 1930's and represent some of
the earliest experimental findings in carcinogenesis.
Some observations can now be explained on the
basis of metabolic detoxification. For example, the
puzzling finding in 1941 that liver cancer induced by
an azo dye could be prevented by high doses of
Vitamin B2 (riboflavin) (10) has later on been ex-
plained in experiments which showed that the azo
linkage is hydrogenated through an enzymatic reac-
tion which requires a coenzyme containing ribofla-
vin (11). The azo dye is thus detoxified, since the
molecule is split into two inactive amines. This ob-
servation has engendered innumerable studies. A
possible human correlation would be that individu-
als who are deficient in riboflavin might be less able
to deactivate an azo dye.
The complex role ofnutrition in carcinogenesis is
yet another factor which may influence thresholds
for carcinogenesis. Overeating, especially a high fat
intake, appears to be a factor in carcinogenesis.
This condition is based on the finding that a high
incidence of skin (12) and breast tumors (13) was
produced in experiments on rodents first given a
polycyclic hydrocarbon initiator and then fed a high
fat diet. A specific component or contaminant offat
has not been identified as a causal factor; only the
intake of excess fat has been implicated.
The foregoing examples illustrate some of the
many conditions, most ofthem complex and only in
the early stages of scientific exploration, that may
influence thresholds for carcinogenesis. However,
there are several additional generalizations which
are pertinent to an argument in favor ofthresholds.
First, it is obvious, as pointed out in Dr. Rall's
paper, that the threshold may be moved upward and
downward by a number offactors that are temporal
in nature. In other words, thresholds at any given
point in time may be different due to a variety of
factors such as intercurrent disease, dietary
splurges, exposures to other chemicals, etc. The
latter may for instance preempt detoxification of a
carcinogen because of the abundance of the other
xenobiotics.
Second, it is important to realize that there are
situations where a recognized chemical carcinogen
is an essential constituent of the mammalian sys-
tem. For example, estrogen at the levels normally
present in the human body does not constitute a
carcinogenic risk despite the evidence that this
hormone in large amounts may be a carcinogen.
Even if estrogens were carcinogenic at physiologic
levels, any attempt to eliminate them from the body
by whatever means would be disastrous to human
development and function. It is also important, in
any consideration of thresholds, to understand that
this situation is not unique for sex hormones. Other
essential chemical constituents of the mammalian
organism may be carcinogens at high doses. These
also include some trace elements, like nickel or ar-
senic, which are present in every tissue and organ.
The fact that a number ofessential chemical con-
stitutents of the body are carcinogens is major evi-
dence forthe reality ofthresholds incarcinogenesis.
The concentrations of these chemicals which are
absolutely necessary fornormal physiologic activity
are obviously below their carcinogenic concentra-
tions since no cancer is induced despite their pre-
sence throughout life.
The evidence I have presented for the existence
of thresholds in carcinogenesis has been limited to
the first phases of carcinogenesis. I have left in the
dark the lengthy chain of events that must occur
after the carcinogen enters the cell and reacts with
the DNA and before the initiated cells start to mul-
tiply and spread throughout the organism.
However, even within this limited view of car-
cinogenesis, there is ample reason to believe that
thresholds do exist for cancer. The major support
for this conclusion stems from the considerations I
have outlined, including the small percentage of
exogenous carcinogenic molecules that ultimately
express their activity once in the organism, the
variables that affect DNA repair and mutation, the
action of promoters, the interactions between car-
cinogens and related compounds, the several
known processes inhibitory to carcinogenesis, and
the fact that a number ofcarcinogenic molecules in
low concentrations are essential constituents ofthe
mammalian system throughout life without causing
cancer.
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